Skip to content
    AMN
    Earnings call· Jun 2026(Q2 FY26)

    AMN HEALTHCARE SERVICES Q2 FY26 earnings call AMN

    Aug 6, 2026 Source

    Executive summary

    AMN Healthcare Q2 FY26 — Strong Revenue Growth and Improved Outlook

    AMN Healthcare delivered strong Q2 FY26 results, exceeding revenue and EBITDA guidance driven by robust demand in Nurse and Allied Solutions, particularly travel nurse and allied volume. While some segments faced headwinds like pricing pressure in language services and declines in locum tenens, the company is leveraging technology and strategic acquisitions to enhance its offerings and capitalize on increasing contingent labor demand. Management expressed optimism for Q3 and 2027 growth, supported by a strengthened balance sheet and potential for market consolidation.

    Highlights

    5
    • Consolidated revenue of $673 million, 6% above the high end of guidance and 2% higher year-over-year.

    • Adjusted EBITDA of $73 million, up 26% year-over-year, representing 10.9% of revenue.

    • Adjusted EPS came in at $0.77, compared with $0.30 in the year ago quarter.

    • Nurse and Allied Solutions segment revenue grew 11% year-over-year to $422 million, 12% ahead of consensus estimates.

    • Travel nurse orders were up about 40% year-over-year and 20% higher than August 2024 as of early August.

    Concerns

    5
    • Physician and Leadership Solutions segment revenue was $165 million, lower by 6% year-over-year.

    • Technology and Workforce Solutions segment revenue was $87 million, down 15% year-over-year.

    • Language services pricing was down 8% year-over-year and is expected to remain a headwind for the rest of 2026.

    • Locum tenens revenue was $131 million, lower by 8% year-over-year.

    • International nurse growth for 2027 may be limited to the single-digit range due to Embassy appointment backlogs.

    Guidance & targets

    15
    CategoryTargetConfidence
    Consolidated revenue
    $640 million to $655 million
    high materiality
    High
    Gross margin
    27% to 27.5%
    medium materiality
    High
    Reported SG&A as percentage of revenue
    22% to 22.5%
    medium materiality
    High
    Operating margin
    0.2% to 0.8%
    medium materiality
    High
    Adjusted EBITDA margin
    6.5% to 7%
    high materiality
    High
    Nurse and Allied segment revenue growth
    9% to 11% year-over-year
    medium materiality
    High
    Physician and Leadership Solutions revenue growth
    down 5% to 7% year-over-year
    medium materiality
    High
    Technology and Workforce Solutions revenue growth
    down 11% to 13% year-over-year
    medium materiality
    High
    Travel nurse volume growth
    better than 10% year-over-year
    medium materiality
    High
    Allied volume growth
    better than 10% year-over-year
    medium materiality
    High
    Locum tenens year-over-year growth
    return to year-over-year growth
    medium materiality
    Medium
    Search and leadership businesses year-over-year growth
    double-digit growth
    medium materiality
    High
    Interim leadership year-over-year growth
    get back to growth
    low materiality
    Medium
    International nurse growth
    single-digit range
    medium materiality
    Medium
    Language services pricing compression
    more muted
    low materiality
    Medium

    Segment performance

    3
    SegmentRevenueYoYQoQMargin
    Nurse and Allied Solutions
    Segment revenue was 12% ahead of consensus estimates. Benefited from higher volume, increased demand, and higher-than-expected labor disruption revenue. Gross margin included 490 basis points benefit from non-recurring items.
    Travel nurse volume: 6% YoY growthAllied volume: 7% YoY growthInternational nurse revenue: 23% YoY growthTravel nurse orders: up 40% YoY (early August)Allied orders: mid-teens growth (June and July)Average bill rate: nearly flat YoYAverage work: up 1% YoY
    $422 million11%28.4% gross margin, 13.8% segment operating margin
    Physician and Leadership Solutions
    Segment revenue was in line with guidance. The search business showed a positive inflection. Locum tenens was impacted by a $2 million negative sales adjustment.
    Search business revenue: 27% YoY growthPhysician search new searches: 37% sequentially, 40% YoYExecutive search new searches: 30% YoYLeadership search volume: 60% increaseLocum tenens revenue: $131 millionLocum tenens revenue: down 8% YoYLocum tenens volume: just under 1% increase sequentiallyInterim leadership revenue: $22 millionInterim leadership revenue: down 3% YoY
    $165 milliondown 6%26.5% gross margin
    Technology and Workforce Solutions
    Segment revenue was in line with guidance. Revenue was down 11% YoY excluding the divestiture of SmartSquare. Language services is navigating a transition to a shared service strategy.
    Language services revenue: $70 millionLanguage services revenue: down 8%Language services volume: flat YoYLanguage services pricing: down 8% YoYVMS revenue: $15 millionVMS revenue: down 20% YoY
    $87 milliondown 15%48.6% gross margin

    Operational metrics

    16
    Adjusted EBITDA
    $73 millionup 26% year-over-year
    Q2 FY26
    Adjusted EBITDA margin (normalized)
    top end of 6.7% to 7.2%
    Q2 FY26

    Excluding $27 million in non-recurring items (true-up of billing accruals, reserve reversal, other favorable reserve adjustments).

    Adjusted SG&A
    $135 milliondown 4% compared to prior year
    Q2 FY26
    Cash and equivalents
    $362 million
    Q2 FY26 end

    Above expectation of $175 million primarily due to favorable working capital impacts.

    Total debt
    $750 million
    Q2 FY26 end
    Share repurchases
    85,000 shares
    Q2 FY26
    Passport app users
    400,000+up 33% year-over-year
    Q2 FY26

    Provides AMN with one of the largest clinician networks in health care staffing.

    Passport app monthly active users
    more than 50%over the prior year
    Q2 FY26
    Days sales outstanding (DSO)
    52 days
    Q2 FY26

    Excluding working capital effects from Q1 labor disruption, DSO was 54 days, flat sequentially and 2 days lower year-over-year.

    Labor disruption revenue
    $25 millionabove $10 million guidance assumption
    Q2 FY26
    Non-recurring Q2 items impact
    $27 million
    Q2 FY26

    Includes true-up of billing accruals from large Q1 labor disruption, reserve reversal from prior year event, and other favorable reserve adjustments.

    Strike-related client deposits outstanding
    $117 million
    Q2 FY26 end

    Remaining balance at quarter end.

    Locum tenens sales adjustment
    negative $2 million
    Q2 FY26

    Reduced revenue and gross profit.

    Language services price per minute
    down 3% sequentiallydown 8% year-over-year
    Q2 FY26
    Language services minutes
    up 3% sequentiallyflat year-over-year
    Q2 FY26

    Despite pressures on limited English proficiency population and nominal contribution from new clients.

    Acquisition spend
    $3 million
    Q2 FY26

    For Jaide Health and ESSENTIAL Brand Leadership Assessment solutions.

    Industry KPIs

    2
    MetricValueDetails
    Utilization trendsincreasing
    Adjusted EPS EBITDA leverage guidanceAdjusted EPS $0.77, Adjusted EBITDA $73 million, 10.9% of revenue, 1.5xUSD, %, x

    Product announcements

    4
    ProductTypeDetails
    Jaide Health integrationupdate
    ESSENTIAL Brand Leadership Assessment solutionupdate
    WorkWise platform enhancementsupdate
    Passport app AI-enabled searchupdate

    Deals & partnerships

    2
    Jaide HealthAcquisition of AI-enabled language interpretation services.part of $3 million

    Acquired Jaide Health to extend medically qualified language interpretation services with AI-enabled support for patients before and after clinical interaction.

    ESSENTIAL Brand Leadership AssessmentAcquisition of leadership assessment solution.part of $3 million

    Acquired the ESSENTIAL Brand Leadership Assessment solution to support clients in leadership selection, evaluation and coaching as well as succession planning.

    Risks & headwinds

    4
    Embassy appointment backlog for international nurses2027

    May limit 2027 growth to single digits.

    Mitigation: Discussions about improving appointments; potential opening up as the government's next fiscal year starts.

    Language services pricing compressionRemainder of 2026, potentially muted in 2027

    Pricing down 8% YoY in Q2; expected to continue for the rest of 2026.

    Mitigation: Rolling out lower-cost core service tier, expanding workforce globalization for service delivery, new client wins, client renewals.

    Locum tenens business transformationFull benefits expected in 2027

    Locum tenens revenue down 8% YoY in Q2.

    Mitigation: Undergoing process and technology transformation similar to Nurse and Allied segment to improve fill rates in competitive third-party channels.

    Competitive environment in staffingCurrent

    More suppliers in the industry than historically, creating more competition to fill orders.

    Mitigation: Strong execution, process automation, 24/7 business operations, and AI enablement of recruiting, resulting in higher fill rates.

    What to watch in Q3 FY26

    5

    Nurse and Allied segment revenue growth

    Q3 FY26
    Current11% YoY in Q2 FY26
    Target9%-11% YoY

    Why it matters

    Indicates continued strength in the core business and validates management's positive outlook.

    For the third quarter, we expect Nurse and Allied segment revenue to grow 9% to 11% year-over-year.

    Q&A highlights

    6

    Can you quantify the current premium of contingent labor rates over permanent staff and comment on the penetration rate compared to pre-COVID levels?

    The premium of contingent labor to permanent staff is now in the mid- to high single digits, down from 100% during COVID and mid-to-high teens pre-COVID. Overall client utilization of contingent labor is at or slightly below pre-COVID levels.

    We're now back down into the mid- to high single digits. Some would put that in some markets at actually even lower than that.

    asked by Jeff Silber · answered by Caroline Grace

    3 min read7 chapters

    Detailed Narrative

    01

    Strong Q2 Performance Exceeds Expectations

    AMN Healthcare reported consolidated revenue of $673 million for Q2 FY26, surpassing the high end of its guidance range by 6% and representing a 2% year-over-year increase. Adjusted EBITDA reached $73 million, up 26% year-over-year, with an adjusted EBITDA margin of 10.9%. Adjusted EPS came in at $0.77, a significant increase from $0.30 in the prior year quarter. These results included approximately $27 million in non-recurring📎 revenue and a 370 basis point benefit to adjusted EBITDA margin from billing accrual true-up📎s and reserve reversals.

    02

    Nurse and Allied Solutions Drives Growth Momentum

    The Nurse and Allied Solutions segment was a primary driver of the strong performance, with revenue of $422 million, growing 11% year-over-year and exceeding consensus estimates by 12%. Travel nurse volume increased 6% year-over-year, and Allied volume grew 7% year-over-year, marking the highest growth rates for these businesses in four years. Demand acceleration continued into Q3, with travel nurse orders up 40% year-over-year in early August and Allied orders showing mid-teens growth in June and July. International nurse revenue also contributed with 23% year-over-year growth.

    03

    Mixed Performance in Physician and Leadership Solutions

    The Physician and Leadership Solutions segment reported revenue of $165 million, a 6% decrease year-over-year, aligning with guidance. While locum tenens revenue declined 8% year-over-year to $131 million, impacted by a $2 million negative sales adjustment, the search business showed a positive inflection. Physician search new searches grew 37% sequentially and 40% year-over-year, and executive search saw a 30% year-over-year increase in new searches. Interim leadership revenue was down 3% year-over-year but new searches are building.

    04

    Technology and Workforce Solutions Navigates Pricing Headwinds

    Technology and Workforce Solutions segment revenue was $87 million, down 15% year-over-year, or 11% excluding the SmartSquare divestiture. Language services revenue was down 8% to $70 million, with pricing experiencing an 8% year-over-year compression, though volume remained flat. VMS revenue was $15 million, down 20% from a year ago. The company is implementing a shared service strategy and workforce globalization to stabilize margins and rolling out lower-cost service tiers to compete more broadly.

    05

    Strategic Acquisitions and Capital Allocation

    AMN Healthcare completed two small, strategic acquisitions totaling $3 million: Jaide Health, an AI-enabled language interpretation service, and ESSENTIAL Brand Leadership Assessment, a leadership selection solution. These acquisitions aim to extend capabilities and enhance client offerings. The company ended the quarter with a strong balance sheet, holding $362 million in cash and equivalents and a leverage ratio of 1.5x, positioning it for potential market consolidation and further strategic investments. Modest share repurchases of 85,000 shares were executed at an average price of $26.33.

    06

    Technology and AI-Enabled Solutions

    The company continues to invest in process automation, 24/7 business operations, and AI enablement across its recruiting processes. Enhancements were introduced to the WorkWise labor force management platform, including dashboards with supplier performance and third-party bill and pay rate intelligence. The Passport app, a market-leading clinician platform, also saw enhancements, including AI-enabled search, leading to a 33% year-over-year increase in users to over 400,000 and a 50% increase in monthly active users.

    07

    Market Dynamics and Outlook

    Management highlighted that contingent labor rates are at historically low premiums (mid-to-high single digits) compared to permanent staff, making flexible labor an attractive solution for clients facing increasing patient demand. This dynamic, combined with a slowdown in permanent hiring and normalized retention rates post-COVID, is contributing to the pickup in demand. The company anticipates sustained demand increases, especially with upcoming winter orders, and is executing well with high fill rates across its platforms.

    AI-generated summary of the company’s earnings call. Not investment advice.